Boenning & Scattergood, Inc. Viatris Inc Transaction History

Boenning & Scattergood, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	BUY	$8.48 - $11.13 $142,319 - $186,794	16,783 New	16,783 $143,000
Q1 2022 Apr 14, 2022	SELL	$9.81 - $15.4 $159,736 - $250,758	-16,283 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$12.09 - $14.68 $119,630 - $145,258	-9,895 Reduced 37.8%	16,283 $220,000
Q3 2021 Oct 21, 2021	BUY	$13.25 - $15.13 $19,331 - $22,074	1,459 Added 5.9%	26,178 $354,000
Q2 2021 Jul 21, 2021	BUY	$12.97 - $16.15 $320,605 - $399,211	24,719 New	24,719 $353,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

Stay updated on Boenning & Scattergood, Inc. with notifications on news.